West Coast Financial Has Lowered Johnson & Johnson (JNJ) Stake, Qiagen NV (QGEN) Had 4 Bulls

May 19, 2017 - By Hazel Jackson

West Coast Financial Llc decreased Johnson & Johnson (JNJ) stake by 23.07% reported in 2016Q4 SEC filing. West Coast Financial Llc sold 3,505 shares as Johnson & Johnson (JNJ)’s stock 0.00%. The West Coast Financial Llc holds 11,690 shares with $1.34M value, down from 15,195 last quarter. Johnson & Johnson now has $339.09B valuation. The stock increased 0.24% or $0.3 during the last trading session, reaching $126.97. About shares traded. Johnson & Johnson (NYSE:JNJ) has risen 6.00% since April 19, 2017 and is uptrending. It has by 0.00% the S&P500.

Among 10 analysts covering Qiagen (NASDAQ:QGEN), 4 have Buy rating, 0 Sell and 6 Hold. Therefore 40% are positive. Qiagen had 14 analyst reports since August 3, 2015 according to SRatingsIntel. On Tuesday, March 15 the stock rating was maintained by Citigroup with “Neutral”. The firm has “Neutral” rating given on Thursday, July 30 by Mizuho. The rating was initiated by Stifel Nicolaus on Thursday, November 12 with “Hold”. Barclays Capital maintained Qiagen NV (NASDAQ:QGEN) rating on Thursday, July 30. Barclays Capital has “Overweight” rating and $31 target. The firm has “Overweight” rating by Morgan Stanley given on Tuesday, September 15. The stock has “Neutral” rating by Bank of America on Thursday, November 3. See Qiagen NV (NASDAQ:QGEN) latest ratings:

Analysts await Johnson & Johnson (NYSE:JNJ) to report earnings on July, 18. They expect $1.78 EPS, up 2.30% or $0.04 from last year’s $1.74 per share. JNJ’s profit will be $4.75B for 17.83 P/E if the $1.78 EPS becomes a reality. After $1.83 actual EPS reported by Johnson & Johnson for the previous quarter, Wall Street now forecasts -2.73% negative EPS growth.

Among 15 analysts covering Johnson & Johnson (NYSE:JNJ), 7 have Buy rating, 1 Sell and 7 Hold. Therefore 47% are positive. Johnson & Johnson had 42 analyst reports since August 7, 2015 according to SRatingsIntel. As per Wednesday, October 7, the company rating was maintained by RBC Capital Markets. Barclays Capital downgraded Johnson & Johnson (NYSE:JNJ) on Tuesday, November 29 to “Equal-Weight” rating. The rating was downgraded by Vetr to “Strong-Buy” on Monday, August 31. On Thursday, January 26 the stock rating was downgraded by Wells Fargo to “Market Perform”. Atlantic Securities initiated the stock with “Neutral” rating in Friday, December 18 report. The firm has “Outperform” rating given on Wednesday, January 25 by RBC Capital Markets. The firm has “Overweight” rating given on Tuesday, December 1 by Barclays Capital. The stock of Johnson & Johnson (NYSE:JNJ) earned “Hold” rating by Jefferies on Tuesday, September 13. Jefferies maintained the shares of JNJ in report on Thursday, August 4 with “Hold” rating. The firm has “Buy” rating given on Wednesday, October 19 by UBS.

Since February 1, 2017, it had 0 insider buys, and 5 sales for $14.98 million activity. Another trade for 21,735 shares valued at $2.45 million was made by Ullmann Michael H on Wednesday, February 1. 50,000 shares valued at $6.18M were sold by Duato Joaquin on Friday, March 3. Another trade for 22,000 shares valued at $2.58 million was sold by Stoffels Paulus. 16,299 shares valued at $1.99M were sold by Pruden Gary J on Tuesday, February 28. $1.78 million worth of Johnson & Johnson (NYSE:JNJ) was sold by Kapusta Ronald A.

West Coast Financial Llc increased Ishares Tr (IJR) stake by 36,224 shares to 312,092 valued at $42.92 million in 2016Q4. It also upped Ishares Tr (JKD) stake by 5,137 shares and now owns 15,471 shares. Inc Resh Hldgs Inc (NASDAQ:INCR) was raised too.

Investors sentiment increased to 0.94 in 2016 Q4. Its up 0.12, from 0.82 in 2016Q3. It improved, as 63 investors sold JNJ shares while 834 reduced holdings. 114 funds opened positions while 731 raised stakes. 1.72 billion shares or 0.88% more from 1.71 billion shares in 2016Q3 were reported. Letko Brosseau & Assocs Inc reported 0.84% in Johnson & Johnson (NYSE:JNJ). Ghp Investment Inc stated it has 33,674 shares or 0.72% of all its holdings. Strategic Wealth Advisors Gp Ltd Liability Com owns 1.37% invested in Johnson & Johnson (NYSE:JNJ) for 73,282 shares. Highstreet Asset Mgmt Incorporated accumulated 27,777 shares. Moreover, Bristol John W & Company Inc New York has 5.9% invested in Johnson & Johnson (NYSE:JNJ) for 1.82 million shares. Fairfax Holding Can invested in 1.49% or 151,250 shares. Clifford Swan Invest Counsel Limited Liability Com reported 2.51% of its portfolio in Johnson & Johnson (NYSE:JNJ). Bangor Savings Bank accumulated 13,946 shares or 0.38% of the stock. Drexel Morgan invested 2.44% in Johnson & Johnson (NYSE:JNJ). Counselors holds 162,523 shares or 1% of its portfolio. First Quadrant Lp Ca invested 1.03% in Johnson & Johnson (NYSE:JNJ). The California-based Stevens First Principles Inv Advsrs has invested 0.02% in Johnson & Johnson (NYSE:JNJ). Hillsdale Management holds 0.09% in Johnson & Johnson (NYSE:JNJ) or 3,560 shares. Teachers Retirement Sys Of The State Of Kentucky reported 0.49% of its portfolio in Johnson & Johnson (NYSE:JNJ). Toronto Dominion National Bank & Trust, Ontario – Canada-based fund reported 1.09M shares.

The stock decreased 0.06% or $0.02 during the last trading session, reaching $32.12. About 11,948 shares traded. Qiagen NV (NASDAQ:QGEN) has risen 6.00% since April 19, 2017 and is uptrending. It has by 0.00% the S&P500.

QIAGEN N.V. is a holding company. The company has market cap of $7.33 billion. The Firm is engaged in providing Sample to Insight solutions that transform biological samples into molecular insights. It has a 89.21 P/E ratio. The Company’s Sample to Insight solutions integrate sample and assay technologies, bioinformatics and automation systems.